Campbell & CO Investment Adviser LLC

Position in AMGN — Amgen Inc

CIK 1353570 BALTIMORE, MD

Position in AMGN

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$6,655,403

+$1,690,800 QoQ

Shares Held

18,379

+30.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.35%

of 13F equity value

Holder Rank

#703

of 3,140 holders

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Campbell & CO Investment Adviser LLC holds $29,426,907 across 9 Drug Manufacturers - General names. AMGN ranks #1 (22.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc This page	18,379	$6,655,403
2	AZN	Astrazeneca PLC	29,025	$5,503,720
3	LLY	ELI LILLY & Co	3,682	$4,416,301
4	GSK	GSK plc	83,989	$4,402,703
5	SNY	Sanofi	52,949	$2,258,804
6	GILD	Gilead Sciences, Inc.	17,781	$2,246,451
7	PFE	Pfizer Inc	75,099	$1,808,383
8	BMY	Bristol Myers Squibb Co	23,327	$1,344,101

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,655,403	18,379	+30.3%	Shares	Sole	2026-08-03
2026-03-31	$4,964,603	14,110	-4.4%	Shares	Sole	2026-05-15
2025-12-31	$4,829,131	14,754	+289.8%	Shares	Sole	2026-02-12
2025-09-30	$1,068,127	3,785	-72.7%	Shares	Sole	2025-10-28
2025-03-31	$4,318,394	13,861	-32.9%	Shares	Sole	2025-05-14
2024-12-31	$5,382,216	20,650	+110.9%	Shares	Sole	2025-02-10
2024-09-30	$3,155,402	9,793	+319.9%	Shares	Sole	2024-11-12
2024-06-30	$728,633	2,332	+4.4%	Shares	Sole	2024-08-13
2024-03-31	$635,170	2,234	+37.6%	Shares	Sole	2024-05-10
2023-09-30	$436,466	1,624	-78.9%	Shares	Sole	2023-11-08
2022-12-31	$2,019,438	7,689	+287.4%	Shares	Sole	2023-02-14
2022-06-30	$482,950	1,985	-36.4%	Shares	Sole	2022-08-09
2021-09-30	$663,255	3,119	—	Shares	Sole	2021-11-10
No filing history on record for this holder in this stock.